U.S. shipping 2.58 million more COVID-19 vaccine doses to Philippines
Reuters
Published Sep 16, 2021 05:14PM ET
WASHINGTON (Reuters) -The U.S. government will begin shipping 2.58 million more doses of COVID-19 vaccine to the Philippines on Thursday through the COVAX global distribution program, a White House official said on Thursday.
The latest shipments of vaccines made by Pfizer Inc (NYSE:PFE) and Germany's BioNTech, bring the total number of vaccines sent to the Philippines to just over 9 million, the official said.
Scientific teams and legal and regulatory authorities from both countries worked together to ensure prompt delivery of safe and effective vaccine lots to the Asian nation, the official added.
Last week, U.S. President Joe Biden's national security adviser Jake Sullivan met with the foreign and defense ministers of the Philippines during their visit to Washington to mark the 70th anniversary of the two countries' Mutual Defense Treaty.
At the time, Sullivan announced that the United States would provide an additional $11.3 million in COVID-19 assistance to the Philippines, bringing total U.S. COVID-19 assistance to the Philippines since the start of the pandemic to $37 million, in addition to the millions of vaccine doses donated.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.